Cornerstone Planning’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cornerstone Planning's NVS Position: Q2 2026 in Review
Cornerstone Planning increased its Novartis (NVS) stake by 1.5% in Q2 2026, buying an estimated $27.6K and bringing the position to 12,843 shares worth $2.01M. The position accounts for 0.47% of the portfolio, ranked #71.
Cornerstone Planning first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Cornerstone Planning held 12,843 shares of Novartis worth $2.01M as of Q2 2026.
- Cornerstone Planning bought 184 Novartis shares in Q2 2026, an estimated $27.6K.
- Novartis made up 0.47% of Cornerstone Planning's portfolio in Q2 2026, its #71 holding.
- Cornerstone Planning first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Cornerstone Planning's 13F filing for Q2 2026, filed 30 Jul 2026.